Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
Genes & Development|November 5, 2008
Parathyroid hormone signaling through low-density lipoprotein-related protein 6Mei Wan, Chaozhe Yang, Jun Li, et al.The Journal of Biological Chemistry|July 9, 2014
The combined structural and kinetic characterization of a bacterial nitronate monooxygenase from Pseudomonas aeruginosa PAO1 establishes NMO class I and IIFrancesca Salvi, Johnson Agniswamy, Hongling Yuan, et al.Technology in Cancer Research & Treatment|November 15, 2023
Identification of ALK Mutation in Neuroblastoma on the Point of Molecular HeterogeneityTekincan Çağrı Aktaş, Deniz Kızmazoğlu, Safiye Aktaş, et al.Cancer Medicine|August 23, 2023
Prevalence and spectrum of cancer predisposition germline mutations in young patients with the common late-onset cancersShaoyu Hao, Ximeng Zhao, Yue Fan, et al.International Journal of Cancer|May 14, 2022
Genomic landscape of microsatellite instability in Chinese tumors: A comparison of Chinese and TCGA cohortsZiyu Li, Yongning Jia, Honglin Zhu, et al.Genes, Chromosomes & Cancer|April 9, 2022
Treatment outcomes and prognosis of patients with primary and acquired BRAF-mutated non-small cell lung cancer: A multicenter retrospective studyWenxian Wang, Xiaodong Gu, Jinfei Si, et al.Cells|November 11, 2022
Whole Transcriptome Sequencing Reveals Cancer-Related, Prognostically Significant Transcripts and Tumor-Infiltrating Immunocytes in Mantle Cell LymphomaEsra Esmeray Sönmez, Tevfik Hatipoğlu, Deniz Kurşun, et al.Journal of Genetics and Genomics = Yi Chuan Xue Bao|January 16, 2022
Characteristics of TP53 germline variants and their correlations with Li-Fraumeni syndrome or Li-Fraumeni-like syndrome in Chinese tumor patientsPanwen Tian, Xiaoyan Zhang, Sheng Yang, et al.Frontiers in Oncology|July 7, 2022
Plasma Concentrations and Cancer-Associated Mutations in Cell-Free Circulating DNA of Treatment-Naive Follicular Lymphoma for Improved Non-Invasive Diagnosis and PrognosisTevfik Hatipoğlu, Esra Esmeray Sönmez, Xiaozhou Hu, et al.Cancer Medicine|March 31, 2023
Pathogenic genomic alterations in Chinese pancreatic cancer patients and their therapeutical implicationsZhiming Zhao, Xiaomo Li, Fei Wang, et al.Pageof 4